Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study.

CONCLUSION: Treatment of SAA with omalizumab improves the outcome of associated CRSNP+, thus supporting the concept of a "one airway disease".
PMID: 30931917 [PubMed - indexed for MEDLINE]

Source: Journal of Investigational Allergology and Clinical Immunology - October 9, 2020 Category: Allergy & Immunology Authors: Tiotiu A, Oster JP, Roux PR, Nguyen Thi PL, Peiffer G, Bonniaud P, Dalphin JC, de Blay F Tags: J Investig Allergol Clin Immunol Source Type: research